These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 2505783

  • 1. Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide. An experimental study/short communication.
    Pohl J, Stekar J, Hilgard P.
    Arzneimittelforschung; 1989 Jun; 39(6):704-5. PubMed ID: 2505783
    [Abstract] [Full Text] [Related]

  • 2. Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
    Brock N, Pohl J.
    IARC Sci Publ; 1986 Jun; (78):269-79. PubMed ID: 3108156
    [Abstract] [Full Text] [Related]

  • 3. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
    Ozcan A, Korkmaz A, Oter S, Coskun O.
    Arch Toxicol; 2005 Aug; 79(8):461-5. PubMed ID: 15800758
    [Abstract] [Full Text] [Related]

  • 4. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. 2. Comparative study on the uroprotective efficacy of thiols and other sulfur compounds.
    Brock N, Pohl J, Stekar J.
    Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1155-63. PubMed ID: 7199463
    [No Abstract] [Full Text] [Related]

  • 5. Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds.
    Brock N, Pohl J, Stekar J.
    J Cancer Res Clin Oncol; 1981 Nov; 100(3):311-20. PubMed ID: 6792207
    [Abstract] [Full Text] [Related]

  • 6. Influence of mesna on urotoxic effects of selected bromosubstituted analogs of ifosfamide.
    Kuśnierczyk H, Konarski L, Kowalski P, Radzikowski C.
    Arch Immunol Ther Exp (Warsz); 1997 Nov; 45(1):79-85. PubMed ID: 9090445
    [Abstract] [Full Text] [Related]

  • 7. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
    Andriole GL, Sandlund JT, Miser JS, Arasi V, Linehan M, Magrath IT.
    J Clin Oncol; 1987 May; 5(5):799-803. PubMed ID: 3106585
    [Abstract] [Full Text] [Related]

  • 8. Ternatin, a flavonoid, prevents cyclophosphamide and ifosfamide-induced hemorrhagic cystitis in rats.
    Vieira MM, Macêdo FY, Filho JN, Costa AC, Cunha AN, Silveira ER, Brito GA, Ribeiro RA.
    Phytother Res; 2004 Feb; 18(2):135-41. PubMed ID: 15022166
    [Abstract] [Full Text] [Related]

  • 9. Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.
    Brock N, Stekar J, Pohl J, Niemeyer U, Scheffler G.
    Arzneimittelforschung; 1979 Feb; 29(4):659-61. PubMed ID: 114192
    [Abstract] [Full Text] [Related]

  • 10. Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis.
    Batista CK, Mota JM, Souza ML, Leitão BT, Souza MH, Brito GA, Cunha FQ, Ribeiro RA.
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):71-7. PubMed ID: 16708234
    [Abstract] [Full Text] [Related]

  • 11. Protective effect of ketamine against hemorrhagic cystitis in rats receiving ifosfamide.
    Ozguven AA, Yılmaz O, Taneli F, Ulman C, Vatansever S, Onag A.
    Indian J Pharmacol; 2014 Jan; 46(2):147-51. PubMed ID: 24741183
    [Abstract] [Full Text] [Related]

  • 12. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs.
    Korkmaz A, Oter S, Deveci S, Goksoy C, Bilgic H.
    J Urol; 2001 Sep; 166(3):1119-23. PubMed ID: 11490309
    [Abstract] [Full Text] [Related]

  • 13. Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats.
    Yildirim I, Korkmaz A, Oter S, Ozcan A, Oztas E.
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):469-73. PubMed ID: 15232716
    [Abstract] [Full Text] [Related]

  • 14. Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals.
    Hansen RJ, Ludeman SM, Paikoff SJ, Pegg AE, Dolan ME.
    DNA Repair (Amst); 2007 Aug 01; 6(8):1145-54. PubMed ID: 17485251
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cyclooxygenase-2 contributes to functional changes seen on experimental hemorrhagic cystitis induced by ifosfamide in rat urinary bladder.
    Macedo FY, Mourão LT, Palheta RC, Jucá DM, Lima RC, Neto Jde S, Magalhães PJ, Santos AA, Souza MH, Brito GA, Ribeiro RA.
    Cancer Chemother Pharmacol; 2011 Apr 01; 67(4):935-43. PubMed ID: 20602232
    [Abstract] [Full Text] [Related]

  • 17. Tumor necrosis factor-alpha and interleukin-1beta mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice.
    Ribeiro RA, Freitas HC, Campos MC, Santos CC, Figueiredo FC, Brito GA, Cunha FQ.
    J Urol; 2002 May 01; 167(5):2229-34. PubMed ID: 11956484
    [Abstract] [Full Text] [Related]

  • 18. Continuous subcutaneous administration of mesna to prevent ifosfamide-induced hemorrhagic cystitis.
    Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J.
    Semin Oncol; 1996 Jun 01; 23(3 Suppl 6):97-8. PubMed ID: 8677458
    [Abstract] [Full Text] [Related]

  • 19. Prophylactic intravesical instillation of epinephrine prevents cyclophosphamide-induced hemorrhagic cystitis in rats.
    Chow YC, Yang S, Huang CJ, Tzen CY, Su YH, Wang PS.
    Exp Biol Med (Maywood); 2007 Apr 01; 232(4):565-70. PubMed ID: 17392493
    [Abstract] [Full Text] [Related]

  • 20. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--I. Experimental studies on the urotoxicity of alkylating compounds.
    Brock N, Pohl J, Stekar J.
    Eur J Cancer (1965); 1981 Jun 01; 17(6):595-607. PubMed ID: 7308258
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.